Reversible Parkinsonism and cognitive impairment with valproic acid treatment;Parkinsonismo y deterioro cognitivo reversibles tras tratamiento con ácido valproico

Revista de Neurologia

Volumn 47, Issue 7, 2008, Pages 390-391

  Toribio Díaz, M Elena ^a   Morera Guitart, J ^a   Palao Duarte, S ^a  

^a Hospital de San Vicente   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; VALPROIC ACID;

AGED; ALZHEIMER DISEASE; CASE REPORT; COGNITIVE DEFECT; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LETTER; PARKINSONISM; SEIZURE; SYNCOPE;

EID: 55349091378     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4707.2008387     Document Type: Letter

References (9)

1. Arzimanoglou A, Guerrini R, Aircadi J. Aicardi's epilepsy in children. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 103-4.
2. Ribacoba-Montero R, Martínez-Faedo C, Salas-Puig J. Síndrome de ovario poliquístico y ácido valproico. Rev Neurol 2003; 37: 975-82.
3. Durán-Ferreras E, Jiménez-Vilches PL, Galán-Barranco JM, Fernández-Bolaños Porras R. Encefalopatía hiperamoniémica por ácido valproico. Rev Neurol 2008; 46: 537-9.
4. Reisberg B, Ferris SH, De Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-9.
5. Armon C, Shin C, Millar P, Carwile S, Brown E, Edinger JD, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996; 47: 626-35.
6. Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible parkinsonism with normal β-CI-SPECT in patients exposed to sodium valproate. Neurology 2004; 62: 1435-6.
7. Masmoudi K, Gras-Champel V, Masson H, Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsichiatry 2006; 39: 9-12.
8. Masmoudi K, Gras-Champel V, Bonnet I, Pannier M, Masson H, Rosa A, et al. Dementia and extrapyramidal problems cause by long-term valproic acid. Therapie 2000; 55: 629-34.
9. Ristic A, Vojvodic N, Jankovic S, Sindelic A, Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 2006; 47: 2183-5.